Skip to Content

News

After suicide of nonbinary teen, DOE finds multiple Title IX violations at Oklahoma school district

By Lauren del Valle, CNN (CNN) — After the suicide of a nonbinary student last February spurred a monthslong federal investigation, the US Department of Education found Title IX violations in an Oklahoma public school district including multiple failures to respond to notices of sexual harassment. The DOE’s Office of Civil Rights announced a resolution

Continue Reading

New Pentagon report on UFOs includes hundreds of new incidents but no evidence of aliens

Associated Press WASHINGTON (AP) — A new report from the Pentagon has revealed hundreds of new reports of unidentified aircraft and aerial phenomena, but no indications of extraterrestrial life. The review was completed by a Defense Department office tasked with investigating unidentified aerial encounters and reports. In many cases, investigators determined that witnesses misidentified birds,

Continue Reading

What are recess appointments and how could Trump use them to fill his Cabinet?

Associated Press WASHINGTON (AP) — President-elect Donald Trump is considering recess appointments to skip over Senate confirmations for some of the most powerful positions in the U.S. government. Trump over the weekend demanded that Republican leaders in the Senate agree to allow recess appointments as he fills out his administration. It would be a significant

Continue Reading

Smithfield agrees to pay $2 million to resolve child labor allegations at Minnesota meat plant

Associated Press MINNEAPOLIS (AP) — One of the nation’s largest meat processors has agreed to pay $2 million to resolve allegations of child labor violations at a plant in Minnesota. The state’s labor department said Thursday that its investigation found that Smithfield Packaged Meats employed at least 11 children at its plant in St. James

Continue Reading

European committee takes a second look at Alzheimer’s drug and now says it should be approved

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug. Biogen said Thursday that the drug, known in the U.S. as Leqembi, received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use as a treatment for early Alzheimer’s disease. The

Continue Reading